Medpace Holdings (MEDP) Current Assets (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Current Assets came in at $1.1 billion in Q2 2026, up 101.67% on a YoY basis from $520.8 million in Q2 2025, and down 7.79% quarter-over-quarter from $1.1 billion in Q1 2026.
Analysis
Medpace Holdings (MEDP) Current Assets (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Current Assets for 12 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets rose 101.67% year-over-year to $1.1 billion; the trailing twelve-month figure through Jun 2026 stood at $1.1 billion (up 101.67% YoY), and the FY2025 full-year result was $989.6 million, down 3.85% from the prior year.
- Current Assets declined to $1.1 billion in Q2 2026 per MEDP's latest filing, from $1.1 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $328.9 million in Q2 2022.
- Historically, Current Assets has averaged $671.3 million across 5 years, with a median of $665.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Current Assets slumped 51.66% in 2022, then soared 130.26% in 2024.
- Over 5 years, Current Assets stood at $334.0 million in 2022, then soared by 77.81% to $593.8 million in 2023, then surged by 73.32% to $1.0 billion in 2024, then decreased by 3.85% to $989.6 million in 2025, then advanced by 6.13% to $1.1 billion in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $1.1 billion, $1.1 billion, and $989.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 6.23 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.05 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 3.75 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.53 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 923.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 847.23 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 332.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 19.29 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 8.76 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 3.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 989.62 Mn |
| Sep 30, 2025 | 737.29 Mn |
| Jun 30, 2025 | 520.81 Mn |
| Mar 31, 2025 | 821.44 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.03 Bn |
| Jun 30, 2024 | 872.52 Mn |
| Mar 31, 2024 | 744.90 Mn |
| Dec 31, 2023 | 593.83 Mn |
| Sep 30, 2023 | 448.88 Mn |
| Jun 30, 2023 | 378.93 Mn |
| Mar 31, 2023 | 367.62 Mn |
| Dec 31, 2022 | 333.96 Mn |
| Sep 30, 2022 | 337.74 Mn |
| Jun 30, 2022 | 328.89 Mn |
| Mar 31, 2022 | 355.97 Mn |
| Dec 31, 2021 | 690.91 Mn |
| Sep 30, 2021 | 641.22 Mn |